U.S. Telecom Services and Carriers Stock News

Why CareTrust REIT (CTRE) is on investors’ radar CareTrust REIT (CTRE) has drawn investor attention recently as its shares trade around $39.48, alongside reported annual revenue of $476.393m and net income of $320.538m from its healthcare-focused real estate portfolio. See our latest analysis for CareTrust REIT. Recent trading has been relatively firm, with a 30-day share price return of 5.53% and an 8.73% year to date share price return. The 1-year total shareholder return of 41.00% points...

Stifel Financial Corp. previously declared a US$0.34 per-share cash dividend on its common stock, payable June 15, 2026, to shareholders of record on June 1, 2026, alongside quarterly dividends on its Series B, C, and D preferred shares for the period from March 16, 2026, to June 15, 2026. These dividend decisions, coming shortly after stronger quarterly results and the launch of a new Project Finance platform for energy and infrastructure, highlight how Stifel is balancing shareholder...

Renasant Corporation recently completed a US$300,000,000 Fixed‑to‑Floating Rate Subordinated Notes offering due 2036, priced at 100% with a 6.25% coupon transitioning to a SOFR‑linked floating rate and intended to qualify as Tier 2 regulatory capital. The deal’s junior, subordinated and unsecured structure, combined with potential redemption of existing subordinated notes, reshapes Renasant’s capital stack and future funding flexibility. We’ll now examine how this Tier 2 capital raise and...

NiSource (NI) has just opened 2026 with Q1 revenue of US$2.4b and basic EPS of US$1.07, setting the tone for how its earnings story is evolving against the backdrop of its recent history. Over the last few quarters, the company has seen revenue move from US$1.6b in Q4 2024 to US$2.4b in Q1 2026. Quarterly basic EPS has ranged from US$0.20 to just over US$1.00, giving investors a clear view of how earnings scale with the top line. With trailing twelve month EPS at US$2.03 and net profit margin...

Bowhead Specialty Holdings (BOW) opened Q1 2026 with total revenue of US$155.7 million and basic EPS of US$0.49, setting a clear marker for how the year is starting. The company reported an increase in total revenue from US$122.7 million in Q1 2025 to US$155.7 million in Q1 2026, while basic EPS over the same quarters rose from US$0.35 to US$0.49, giving investors a direct view of both top line and per share performance. With trailing net profit margin at around 10%, this set of results keeps...

Relay Therapeutics (RLAY) opened 2026 with Q1 revenue of US$3 million, basic EPS of a US$0.41 loss, and a net loss excluding extra items of US$73.3 million, setting a clear snapshot of where the business is starting the year. The company has seen quarterly revenue move between US$0 and US$7.7 million since early 2024, while basic EPS has ranged from a US$0.32 loss to a US$0.46 loss over the same period, giving investors a consistent view of a revenue generating but loss making biotech with...

FormFactor (FORM) has opened 2026 with Q1 revenue of US$226.1 million and basic EPS of US$0.26, alongside trailing 12 month revenue of US$839.8 million and basic EPS of US$0.88 that reflect the latest reported earnings base. The company has seen quarterly revenue move from US$171.4 million in Q1 2025 to US$226.1 million in Q1 2026, with basic EPS shifting from US$0.08 to US$0.26 over the same period, setting up a results season in which investors can weigh that earnings profile against the...

Earnings reset and guidance cut put Clorox’s near term in focus Clorox (CLX) recently reported mixed third quarter results and sharply reduced its full year earnings outlook, a combination that put margin pressures and execution questions front and center for stock investors. See our latest analysis for Clorox. The updated outlook helped drive a 14.19% 30 day share price decline and a 23.47% 90 day share price return, while the 1 year total shareholder return of 31.08% loss underlines that...

If you are wondering whether Pfizer at a last close of US$26.53 still offers solid value, the starting point is understanding what that price really implies about the business. Over the last year the stock returned 24.9%, with a 5.4% gain year to date, a 1.0% rise over the past week, and a 4.7% decline across the last 30 days, which signals that expectations and perceived risk have been shifting recently. Recent headlines have focused on Pfizer's efforts to reshape its portfolio and...

Global Net Lease (GNL) opened 2026 with Q1 revenue of US$109.3 million and basic EPS of a US$0.09 loss per share, keeping investors focused on how the income statement is tracking against past quarters. The company has seen quarterly revenue move from US$137.8 million in Q4 2024 to US$132.4 million in Q1 2025, then to US$124.9 million, US$121.0 million and US$117.0 million through 2025, alongside basic EPS that has ranged between a loss of US$0.46 per share and a profit of US$0.19 per share...

Fabrinet (FN) has just posted Q3 2026 results with revenue of US$1.2 billion, basic EPS of US$3.49 and net income of US$125.2 million, against a backdrop of 29% reported earnings growth over the last year and a trailing 12 month earnings growth rate of 19.2% per year over the past five years. The company has seen revenue move from US$871.8 million in Q3 2025 through US$909.7 million in Q4 2025 and US$978.1 million in Q1 2026 to US$1.2 billion in Q3 2026. Over the same span, basic EPS has gone...

Astera Labs (ALAB) has put up another active quarter, with Q1 2026 revenue of US$308.4 million and basic EPS of US$0.47, at a time when trailing 12 month EPS sits at US$1.59 on revenue of about US$1.0 billion and net income of US$267.6 million. This comes alongside very large year on year earnings growth and higher profit margins over the past year. Over the last five reported quarters, revenue has moved from US$159.4 million in Q1 2025 to US$308.4 million in Q1 2026, while quarterly EPS has...

Jacobs Solutions (J) opened Q2 2026 with revenue of about US$3.7b and a basic EPS loss of US$0.32, putting a negative earnings print alongside a higher top line. The company has seen quarterly revenue move from about US$2.9b in Q2 2025 to about US$3.7b in Q2 2026, while basic EPS shifted from US$0.10 in Q2 2025 to a loss of US$0.32 this quarter, setting up a mixed read on growth versus profitability that puts the spotlight firmly on margins and earnings quality. See our full analysis for...

Gulfport Energy (GPOR) opened 2026 with Q1 revenue of US$453.3 million and basic EPS of US$8.94, setting the tone for what the latest results say about margins and pricing across its portfolio. Over recent quarters, revenue has moved from US$338.1 million in Q1 2025 to US$350.1 million in Q4 2025 and now US$453.3 million in Q1 2026, while basic EPS has shifted from a small loss of US$0.07 in Q1 2025 to US$6.90 in Q4 2025 and US$8.94 in the latest quarter. With trailing twelve month EPS at...

Marqeta (MQ) has just posted its Q1 2026 scorecard, reporting revenue of US$165.8 million and basic EPS of US$0.02, with the trailing twelve months showing total revenue of US$651.6 million and basic EPS of US$0.00. Over recent quarters, revenue has ranged from US$135.8 million in Q4 2024 to US$172.1 million in Q4 2025, while quarterly basic EPS has moved from a loss of US$0.05 in Q4 2024 to a profit of US$0.02 in Q1 2026. This sets up a results season in which the key question for investors...

CF Bankshares (CFBK) opened 2026 with Q1 total revenue of about US$14.2 million and basic EPS of roughly US$0.77, set against trailing 12 month revenue of about US$53.4 million and EPS of roughly US$2.79 that reflect 22.8% earnings growth over the past year. Over recent periods, the company has seen quarterly revenue move from about US$13.5 million in Q1 2025 to roughly US$14.2 million in Q1 2026, while basic EPS shifted from about US$0.68 to roughly US$0.77, supported by trailing net profit...

In the first quarter of 2026, Balchem Corporation reported higher sales of US$270.71 million and net income of US$40.29 million, alongside completing a share repurchase of 159,539 shares for US$25.85 million under its December 2025 buyback program. The combination of earnings growth and active capital returns signals management’s focus on both expanding the business and returning excess cash to shareholders. We’ll now examine how Balchem’s stronger earnings and completed buyback program...

Edgewell Personal Care (EPC) has put fresh numbers on the table for Q2 2026, reporting revenue of US$519.5 million and basic EPS of US$0.09. This comes against a backdrop of trailing 12 month revenue of US$2.2 billion and a basic EPS loss of US$0.23. Over the past few quarters the company has seen revenue move between US$415.1 million and US$627.2 million, while basic EPS has swung from a loss of US$0.66 to a profit of US$0.62. This performance sets the scene for investors to focus on how...

Sinclair (SBGI) has drawn fresh attention after recent price moves, with the stock up about 12% over the past month and roughly 8% in the past 3 months, compared with a modest 1-year total return. See our latest analysis for Sinclair. The recent 30 day share price return of 11.67% and 90 day share price return of 8.25% contrast with a modest 1.14% 1 year total shareholder return, which suggests that momentum has increased only in the shorter term. If Sinclair's moves have your attention, it...

Belden Inc. has reported past first-quarter 2026 results, with sales rising to US$696.38 million and GAAP diluted EPS from continuing operations at US$1.30, and has also issued second-quarter 2026 guidance for revenues of US$735 million to US$750 million and GAAP EPS of US$1.53 to US$1.63. Together with progress on its Joseph C. Belden Innovation Award finalists, these figures highlight how Belden is pairing earnings stability with initiatives that promote IT/OT convergence and data-driven...

California Resources (CRC) opened 2026 with Q1 revenue of US$967 million and a basic EPS loss of US$8.02 per share, setting a stark headline for the latest quarter. The company has seen quarterly revenue move between US$798 million and US$926 million over the last year, while EPS shifted from a profit of US$1.93 in Q2 2025 to smaller profits in subsequent quarters before this latest loss. This leaves investors weighing solid top line scale against pressure on margins. See our full analysis...

Ingredion (NYSE:INGR) plans to cease operations at its Cabo manufacturing facility in Brazil by 2026. The company is experiencing operational challenges at its Argo facility, contributing to higher costs. Management reduced full year earnings guidance in response to these operational issues. Ingredion, a key supplier of ingredient solutions for food, beverage, and industrial customers, is reshaping its manufacturing footprint while dealing with disruptions at a core US site. The Cabo...

Concentrix (CNXC) is back in focus after its fiscal Q1 2026 earnings. Solid revenue growth contrasted with a sharp drop in operating and net income, prompting a strong market and analyst reaction. See our latest analysis for Concentrix. The Q1 earnings miss and a 6,000,000 share secondary sale by a large shareholder have coincided with sharp weakness. The 30 day share price return of 13.68% and the 1 year total shareholder return decline of 51.2% signal fading momentum after a longer period...

MasterBrand (MBC) opened Q1 2026 with revenue of US$618 million and a basic EPS loss of US$0.12, while trailing 12 month figures show revenue of about US$2.7 billion and a marginal basic EPS loss of US$0.02, underscoring pressure on profitability. Over recent quarters the company has seen revenue move between US$660.3 million in Q1 2025 and US$730.9 million in Q2 2025, alongside basic EPS shifting from a profit of US$0.29 in Q2 2025 to a loss of US$0.33 in Q4 2025. This sets the stage for...